BIOLAN launches its rapid antibody detection test for COVID-19 with a guaranteed industrial production capacity

The member of the Basque Health Cluster located in Zamudio has made a significant investment in the equipment necessary to scale up this newly developed product. Since January, BIOLAN has had a new developed and validated product with excellent sensitivity (96%) and specificity (93%) results and meeting all the necessary requirements for going to market,…

Histocell and Cardiva sign agreement for distribution of Reoxcare nationwide

The Basque bio-pharmaceutical company Histocell and the Cardiva Group, both members of the Basque Health Cluster, have joined forces to launch the innovative wound healing product Reoxcare across the whole Spanish healthcare system. The Basque bio-pharmaceutical company Histocell, specialising in regenerative medicine, is the developer and manufacturer of Reoxcare, the antioxidant treatment using natural ingredients for healing chronic…

Basque Health Cluster meets with the Regional Councillor Gotzone Sagardui

On 14 January the Basque Health Cluster met with the Regional Councillor for Health, Gotzone Sagardui. The representatives for the Health Cluster were President Mikel Alvarez, Vicepresident Julio Font and Secretary/Treasurer Asier Albizu, alongside Basque Health Cluster Managing Director María Pascual de Zulueta. This working meeting examined critical development factors for businesses in this sector,…

6 May: 6th Health Industry Meeting for New Aquitaine/Basque Country/Navarre

This year, the 6th Bio-health industry meeting for New Aquitaine/Basque Country/Navarre will be held virtually in Bordeaux as a satellite event of the Meet2Win convention.   Full information HERE   The purpose of the Meetings is to promote cross-border projects with collaboration between industries and researchers from public and private organisations in the health sector from…

OWL and Biosfer join forces to reinforce metabolomics in the diagnosis and treatment of illness

The two companies, representatives of diagnosis solutions based on metabolomic technology, have signed a collaboration agreement to strengthen R&D in the sector. The Basque biotechnology firm OWL will contribute know-how in the creation of non-invasive diagnosis solutions for Non-Alcoholic Steatohepatitis (NASH). The goal is to encourage the use of metabolomic technology in the research and…

Euskadi Next 21-26

This Tuesday, 29/12/2020, the Basque Government approved the first version of the programme Euskadi Next 21-26, for the recovery, transformation and resilience of Euskadi. The Basque Government has drawn up the programme Euskadi Next 21-26 in collaboration with the provincial and local authorities of the three Basque regions, for submission to the Central Government for it to be included in…

Technological solutions for COVID-19: PRAP Euskadi

The PRAP EUSKADI initiative is now available for companies interested in monitoring the incidence of COVID-19 within their organisation. PRAP EUSKADI is an initiative supported by the Department of Economic Development, Sustainability and the Environment of the Basque Government intended to minimise the economic impact that companies in the Basque Country may suffer due to the COVID-19 pandemic. It…